Copyright
        ©The Author(s) 2015.
    
    
        World J Stem Cells. Oct 26, 2015; 7(9): 1185-1201
Published online Oct 26, 2015. doi: 10.4252/wjsc.v7.i9.1185
Published online Oct 26, 2015. doi: 10.4252/wjsc.v7.i9.1185
            Table 1 Cell surface antigens present on cancer stem cells
        
    | Cancer type | Surfaceantigens | Ref. | 
| Leukemia | CD34+CD38-CD47+CCL-1+CD96+ TIM3+CD32+CD25+ | [11,20-24] | 
| Brain | CD133+ | [12] | 
| Head and neck | CD44+CD24+ | [14] | 
| Breast | ESA+CD44+CD24- | [13,16] | 
| Pancreatic | ESA+CD44+CD24+ | [13,40] | 
| Lung | CD133+CD44+ | [15] | 
| Liver | ESA+CD133+CD90+CD44+CD24+ | [17] | 
| Gastric | CD44+ | [18,38] | 
| Colorectal | ESA+CD133+CD166+CD44+CD24+ | [19,26] | 
- Citation: Dragu DL, Necula LG, Bleotu C, Diaconu CC, Chivu-Economescu M. Therapies targeting cancer stem cells: Current trends and future challenges. World J Stem Cells 2015; 7(9): 1185-1201
- URL: https://www.wjgnet.com/1948-0210/full/v7/i9/1185.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v7.i9.1185

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        